The story so far: Last week, India reached out to Australia to procure monoclonal antibody doses to combat the Nipah virus outbreak in Kerala. According to research published in The Lancet journal of Infectious Diseases, m102.4 is a “potent, fully human” monoclonal antibody that neutralises Hendra and Nipah viruses, both outside and inside of living organisms. According to a research …
